Logo image of NTSK

NETSKOPE INC-CL A (NTSK) Stock Fundamental Analysis

USA - NASDAQ:NTSK - US64119N6085 - Common Stock

18.12 USD
+0.22 (+1.23%)
Last: 11/21/2025, 11:39:09 AM
Fundamental Rating

1

Overall NTSK gets a fundamental rating of 1 out of 10. We evaluated NTSK against 281 industry peers in the Software industry. NTSK may be in some trouble as it scores bad on both profitability and health. NTSK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NTSK has reported negative net income.
NTSK had a positive operating cash flow in the past year.
NTSK Yearly Net Income VS EBIT VS OCF VS FCFNTSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2025 -100M -200M -300M

1.2 Ratios

NTSK's Return On Assets of -42.93% is on the low side compared to the rest of the industry. NTSK is outperformed by 81.85% of its industry peers.
Industry RankSector Rank
ROA -42.93%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NTSK Yearly ROA, ROE, ROICNTSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2025 0 20 -20 40 -40 60 -60

1.3 Margins

NTSK has a Gross Margin (64.68%) which is comparable to the rest of the industry.
The Profit Margin and Operating Margin are not available for NTSK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NTSK Yearly Profit, Operating, Gross MarginsNTSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2025 0 20 -20 40 -40 60 -60

More info and screens

0

2. Health

2.1 Basic Checks

NTSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
NTSK Yearly Shares OutstandingNTSK Yearly Shares OutstandingYearly Shares Outstanding 2025 100M 200M 300M
NTSK Yearly Total Debt VS Total AssetsNTSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2025 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -1.17, we must say that NTSK is in the distress zone and has some risk of bankruptcy.
NTSK's Altman-Z score of -1.17 is on the low side compared to the rest of the industry. NTSK is outperformed by 75.09% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.17
ROIC/WACCN/A
WACC10.92%
NTSK Yearly LT Debt VS Equity VS FCFNTSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2025 0 200M -200M 400M -400M 600M

2.3 Liquidity

A Current Ratio of 0.92 indicates that NTSK may have some problems paying its short term obligations.
NTSK has a Current ratio of 0.92. This is in the lower half of the industry: NTSK underperforms 77.58% of its industry peers.
NTSK has a Quick Ratio of 0.92. This is a bad value and indicates that NTSK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.91, NTSK is doing worse than 77.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.91
NTSK Yearly Current Assets VS Current LiabilitesNTSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2025 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%30.68%

3.2 Future

The Earnings Per Share is expected to grow by 18.33% on average over the next years. This is quite good.
The Revenue is expected to grow by 25.48% on average over the next years. This is a very strong growth
EPS Next Y-58.79%
EPS Next 2Y18.93%
EPS Next 3Y18.33%
EPS Next 5YN/A
Revenue Next Year30.81%
Revenue Next 2Y26.92%
Revenue Next 3Y25.48%
Revenue Next 5YN/A

3.3 Evolution

NTSK Yearly Revenue VS EstimatesNTSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 200M 400M 600M 800M 1B
NTSK Yearly EPS VS EstimatesNTSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 -0.5 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NTSK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NTSK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NTSK Price Earnings VS Forward Price EarningsNTSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NTSK Per share dataNTSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as NTSK's earnings are expected to grow with 18.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.93%
EPS Next 3Y18.33%

More info and screens

0

5. Dividend

5.1 Amount

NTSK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NETSKOPE INC-CL A

NASDAQ:NTSK (11/21/2025, 11:39:09 AM)

18.12

+0.22 (+1.23%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)12-11 2025-12-11
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change-2.43%
Market Cap6.92B
Revenue(TTM)538.00M
Net Income(TTM)-355.00M
Analysts85.26
Price Target27.54 (51.99%)
Short Float %6.3%
Short Ratio2.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.87
P/FCF N/A
P/OCF 1866.07
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.93
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.01
OCFY0.05%
SpS1.41
BVpS-1.6
TBVpS-1.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -42.93%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.68%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.82%
Cap/Sales 5.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.91
Altman-Z -1.17
F-ScoreN/A
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.52%
EPS Next Y-58.79%
EPS Next 2Y18.93%
EPS Next 3Y18.33%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%30.68%
Revenue Next Year30.81%
Revenue Next 2Y26.92%
Revenue Next 3Y25.48%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NETSKOPE INC-CL A / NTSK FAQ

Can you provide the ChartMill fundamental rating for NETSKOPE INC-CL A?

ChartMill assigns a fundamental rating of 1 / 10 to NTSK.


Can you provide the valuation status for NETSKOPE INC-CL A?

ChartMill assigns a valuation rating of 0 / 10 to NETSKOPE INC-CL A (NTSK). This can be considered as Overvalued.


What is the profitability of NTSK stock?

NETSKOPE INC-CL A (NTSK) has a profitability rating of 1 / 10.


How financially healthy is NETSKOPE INC-CL A?

The financial health rating of NETSKOPE INC-CL A (NTSK) is 0 / 10.